Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total		At-the-Market [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Alef [Member]	Natura Naturals Inc	Natura Contingent Consideration	Manitoba Harvest U S L L C	Investments	S And S Acquisition	ABG [Member]	Preferred Shares [Member]	Common Stock [Member]	Common Stock [Member] At-the-Market [Member]	Common Stock [Member] Alef [Member]	Common Stock [Member] Natura Naturals Inc	Common Stock [Member] Natura Contingent Consideration	Common Stock [Member] Manitoba Harvest U S L L C	Common Stock [Member] Investments	Common Stock [Member] S And S Acquisition	Common Stock [Member] Downstream Merger [Member]	Common Stock [Member] ABG [Member]	Additional Paid-In Capital [Member]	Additional Paid-In Capital [Member] At-the-Market [Member]	Additional Paid-In Capital [Member] Alef [Member]	Additional Paid-In Capital [Member] Natura Naturals Inc	Additional Paid-In Capital [Member] Natura Contingent Consideration	Additional Paid-In Capital [Member] Manitoba Harvest U S L L C	Additional Paid-In Capital [Member] Investments	Additional Paid-In Capital [Member] S And S Acquisition	Additional Paid-In Capital [Member] ABG [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Other Comprehensive Income [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Deficit [Member] ABG [Member]
Beginning Balance at Dec. 31, 2017	$ (4,852)																						$ 31,736									$ 3,866		$ (40,454)
Shares issued for preferred shares, net of issuance costs	52,560											$ 2											52,558
Shares issued for preferred shares, net of issuance costs, shares												7,794,042
Conversion of preferred shares	(2)	[1]										$ (2)	$ 2
Conversion of preferred stock, shares												(7,794,042)	7,794,042
Shares issued for acquisition					$ 2,855																				$ 2,855
Shares issued for acquisition, shares															26,825
Common stock issuance, net of issuance costs	160,792												$ 8										160,784
Common stock issuance, net of issuance costs, shares													85,350,000
Stock-based compensation expenses	20,988																						20,988
Other comprehensive (loss) income	(103)																															(103)
Deferred tax liability related to convertible notes, net of issuance costs	(8,809)																						(8,809)
Equity component related to issuance of convertible notes, net of issuance costs	41,945																						41,945
Net loss	(67,723)																																	(67,723)
Ending Balance at Dec. 31, 2018	197,653												$ 10										302,057									3,763		(108,177)
Ending Balance (ASU 2016-01 [Member]) at Dec. 31, 2018																																	$ 803		$ (803)
Ending Balance (ASC 842 [Member]) at Dec. 31, 2018				$ 19																															$ 19
Ending Balance, Shares at Dec. 31, 2018													93,170,867
Shares issued for acquisition						$ 15,099	$ 4,450	$ 128,710	$ 10,551	$ 3,189	$ 125,097															$ 15,099	$ 4,450	$ 128,710	$ 10,551	$ 3,189	$ 125,097
Shares issued for acquisition, shares																180,332	238,826	2,109,252	550,646	79,289	(2,212,025)	1,680,214
ABG finance receivable, net of finance income											(27,553)																				(27,553)
Shares issued under stock-based compensation plans	506																						506
Shares issued under stock-based compensation plans, shares													1,575,455
Common stock issuance, net of issuance costs			$ 111,073											$ 1										$ 111,072
Common stock issuance, net of issuance costs, shares														5,396,501
Shares issued for employee compensation	651																						651
Shares issued for employee compensation, shares													11,868
Stock-based compensation expenses	31,842																						31,842
Other comprehensive (loss) income	5,153																															5,153
Net loss	(321,169)																																	(321,169)
Ending Balance at Dec. 31, 2019	285,271												$ 11										705,671									9,719		(430,130)
Ending Balance, Shares at Dec. 31, 2019													102,781,225
Proceeds from ABG Profit Participation Arrangement											$ 1,353																				1,353
Write-off of ABG finance receivable																															$ 28,900					$ (28,900)
Escrow shares released from downstream merger	(644)																						(644)
Escrow shares released shares from downstream merger, shares													(61,776)
Shares issued under registered offering, net of issuance costs	19,829												$ 1										19,828
Shares issued under registered offering, net of issuance costs, Shares													7,250,000
Shares issued for exercise of pre-funded warrants	49,055												$ 1										49,054
Shares issued for exercise of pre-funded warrants, shares													11,750,000
Shares issued for acquisition	2,215																						2,215
Shares issued for acquisition, shares													286,618						6,934
Shares issued under stock-based compensation plans	11,284																						11,284
Shares issued under stock-based compensation plans, shares													2,972,022
Common stock issuance, net of issuance costs			$ 125,143											$ 1										$ 125,142
Common stock issuance, net of issuance costs, shares														16,131,487
Shares issued for convertible debt settlement	123,264												$ 2										123,262
Shares issued for convertible debt settlement, shares													17,339,577
Stock-based compensation expenses	29,716																						29,716
Other comprehensive (loss) income	(1,514)																															(1,514)
Net loss	(271,073)																																	(271,073)
Ending Balance at Dec. 31, 2020	$ 373,899												$ 16										$ 1,095,781									$ 8,205		$ (730,103)
Ending Balance, Shares at Dec. 31, 2020													158,456,087

[1] For supplemental cash flow information related to leases, refer to Note 10.